α-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-α

Diabetes

Volumn 51, Issue 10, 2002, Pages 3049-3054

  Venugopal, Senthil Kumar ^a   Devaraj, Sridevi ^a   Yang, Teddy ^a   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTISENSE OLIGODEOXYNUCLEOTIDE; APOCYNIN; DIPHENYLIODONIUM SALT; ISOPROTEIN; OXYGEN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MITOCHONDRIAL RESPIRATION; MONOCYTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0036787465     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.3049     Document Type: Article

References (25)

1. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L: The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212, 2001
2. Devaraj S, Jialal I: Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation. Circulation 102:191-196, 2000
3. Santiago JV: Lessons from the Diabetes Control and Complications Trial (Review). Diabetes 42:1549-1554, 1993
4. Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
5. Nishikawa T, Edilstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes H, Glardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
6. Koya D, King G: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
7. - production and low density lipoprotein lipid oxidation. J Biol Chem 274:3764-3771, 1999
8. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways, J Clin Invest 103:185-195, 1999
9. Babior BM: NADPH oxidase: an update. Blood 93:1464-1476, 1999
10. Jain SK: Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 264:21340-21345, 1989
11. Kadri-Hassani N, Leger CL, Descomps B: The fatty acid bimodal action on superoxide production by human adherent monocytes under phorbol 12-myristate 13-acetate or diacylglycerol activation can be explained by the modulation of protein kinase C and p47phox translocation. J Biol Chem 270:15111-15118, 1995
12. Stampfer M, Hennekins C, Manson J, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 328:1444-1449, 1993
13. Rimm E, Stampfer M, Ascherio A, Giovannucci E, Colditz GA, Willett WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450-1456, 1993
14. Devaraj S, Jialal I: The effects of alpha-tocopherol on critical cells in atherogenesis. Curr Opin Lipidol 9:11-15, 1998
15. Devaraj S, Jialal I: Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med 29:790-792, 2000
16. Devaraj S, Hirany SV, Burk RF, Jialal I: Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem 47:1974-1979, 2001
17. Trachtman H, Futterweit S, Prenner J, Hanon S: Antioxidants reverse the anti-proliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells. Biochem Biophys Res Commun 199:346-532, 1994
18. Ceolotto G, Gallo A, Miola M, Sartori M, Trevisan R, Del Prato S, Semplicini A, Avogaro A: Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 48:1316-1322, 1999
19. Dieter P, Schwende H: Protein kinase C-α and -β play antagonistic roles in the differentiation process of THP-1 cells. Cell Signal 12:297-302, 2000
20. Bey EA, Cathcart MK: In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes. J Lipid Res 41:489-495, 2000
21. Abrink M, Gobl AE, Huang R, Nilsson K, Hellman L: Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage. Leukemia 8:1579-1584, 1994
22. Li Q, Cathcart MK: Protein kinase C activity is required for lipid oxidation of low density lipoprotein by activated human monocytes. J Biol Chem 269:17508-17515, 1994
23. Ganz MB, Seftel A: Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiol Endocrinol Metab 278: E146-E152, 2000
24. Cachia O, Benna JE, Pedruzzi E, Descomps B, Gougerot-Pocidalo M, Leger C: α-Tocopherol inhibits the respiratory burst in human monocytes. J Biol Chem 273:32801-32805, 1998
25. Mathur A, Vallano ML: 2,2′,3,3′,4,4′-Hexahydroxy-1,1′-biphenyl-6, 6′-dimethanol dimethyl ether (HBDDE)-induced neuronal apoptosis independent of classical protein kinase C alpha or gamma inhibition. Biochem Pharmacol 60:809-815, 2000